TR200401906T4 - Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır. - Google Patents
Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır.Info
- Publication number
- TR200401906T4 TR200401906T4 TR2004/01906T TR200401906T TR200401906T4 TR 200401906 T4 TR200401906 T4 TR 200401906T4 TR 2004/01906 T TR2004/01906 T TR 2004/01906T TR 200401906 T TR200401906 T TR 200401906T TR 200401906 T4 TR200401906 T4 TR 200401906T4
- Authority
- TR
- Turkey
- Prior art keywords
- pharmaceutical composition
- proton pump
- pump inhibitor
- composition
- optional
- Prior art date
Links
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 3
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 3
- 239000000612 proton pump inhibitor Substances 0.000 abstract 3
- 239000000839 emulsion Substances 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 abstract 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Abstract
Bu icat agizdan alim için uygun bir emülsiyon ön konsantresi biçiminde olan, (i) bir ya da daha fazla NO açiga çikaran NSAID(ler)'den; (ii) bir yada daha fazla yüzey aktif maddeden;(iii) seçime bagli olarak ek bir sivi ya da yari kati yagdan olusan bir farmasötik bilesim açiklamakta ve isteminde bulunmaktadir ki, sözü edilen bilesim mide-bagirsak sivilariyla temas ettiginde bir yerinde su-içinde-sivi yag emülsiyonu olusturur. Bu bilesim istege bagli olarak bir ya da daha fazla kisa zincirli alkol de içerebilir. Ayrica, icadin kapsami içinde, bir proton pompasi inhibitörü ile yapilan bir kombinasyon da vardir. Bu farmasötik bilesim agri ve inflamasyon tedavisinde yararlidir. Ayrica, icadin kapsami içinde, icatta belirtilen farmasötik bir bilesimin birim dozaj biçiminin bir proton pompasi inhibitörüyle kombinasyon halinde bulundugu ve sözü edilen proton pompasi inhibitörünün enterik kaplamali oldugu bir kit de bulunmaktadir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0000773A SE0000773D0 (sv) | 2000-03-08 | 2000-03-08 | New formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200401906T4 true TR200401906T4 (tr) | 2004-09-21 |
Family
ID=20278739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2004/01906T TR200401906T4 (tr) | 2000-03-08 | 2001-03-06 | Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır. |
Country Status (31)
Country | Link |
---|---|
US (1) | US20030161846A1 (tr) |
EP (1) | EP1267832B1 (tr) |
JP (1) | JP4663197B2 (tr) |
KR (1) | KR100771317B1 (tr) |
CN (2) | CN1416335B (tr) |
AT (1) | ATE268162T1 (tr) |
AU (2) | AU2001237876B2 (tr) |
BR (1) | BR0109014A (tr) |
CA (1) | CA2401498C (tr) |
CZ (1) | CZ20023005A3 (tr) |
DE (1) | DE60103627T2 (tr) |
DK (1) | DK1267832T3 (tr) |
EE (1) | EE200200500A (tr) |
ES (1) | ES2220728T3 (tr) |
HK (1) | HK1050632A1 (tr) |
HU (1) | HUP0300882A3 (tr) |
IL (1) | IL151427A0 (tr) |
IS (1) | IS6539A (tr) |
MX (1) | MXPA02008657A (tr) |
MY (1) | MY127237A (tr) |
NO (1) | NO20024272L (tr) |
NZ (1) | NZ521009A (tr) |
PL (1) | PL202683B1 (tr) |
PT (1) | PT1267832E (tr) |
RU (1) | RU2270675C9 (tr) |
SE (1) | SE0000773D0 (tr) |
SK (1) | SK285982B6 (tr) |
TR (1) | TR200401906T4 (tr) |
UA (1) | UA82979C2 (tr) |
WO (1) | WO2001066088A1 (tr) |
ZA (1) | ZA200206740B (tr) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6852739B1 (en) * | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
IT1319202B1 (it) | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per le malattie a base infiammatoria. |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) * | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
SE0200895D0 (sv) * | 2002-03-22 | 2002-03-22 | Astrazeneca Ab | New pharmaceutical composition |
FR2838349B1 (fr) * | 2002-04-15 | 2004-06-25 | Laurence Paris | Compositions liquides pour capsules molle a liberation prolongee et leur procede de fabrication |
ITMI20021392A1 (it) * | 2002-06-25 | 2003-12-29 | Nicox Sa | Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita' |
WO2004004648A2 (en) | 2002-07-03 | 2004-01-15 | Nitromed, Inc. | Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
EP1542972A4 (en) | 2002-07-29 | 2008-01-23 | Nitromed Inc | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITION AND METHOD OF USE |
EP1534278A4 (en) | 2002-08-01 | 2006-09-06 | Nitromed Inc | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD |
FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
SE0301880D0 (sv) * | 2003-06-25 | 2003-06-25 | Astrazeneca Uk Ltd | New drug delivery composition |
KR20050034299A (ko) * | 2003-10-09 | 2005-04-14 | 한국유나이티드제약 주식회사 | 아세클로페낙 자가유화에멀젼 및 이를 이용한 연질캅셀제조성물 및 그의 제조방법 |
NZ564589A (en) * | 2005-07-26 | 2010-01-29 | Nicox Sa | Pharmaceutical formulation of nitrooxyderivatives of NSAIDs |
US20070154542A1 (en) * | 2005-12-30 | 2007-07-05 | Cogentus Pharmaceuticals, Inc. | Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors |
MX2011002515A (es) | 2008-09-09 | 2011-04-07 | Astrazeneca Ab | Metodo de administracion de una composicion farmaceutica a un paciente que lo necesita. |
ES2451540T3 (es) * | 2008-12-03 | 2014-03-27 | Astellas Deutschland Gmbh | Formas de dosificación oral de bendamustina |
US20100273730A1 (en) * | 2009-04-27 | 2010-10-28 | Innopharmax, Inc. | Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof |
MX2011013467A (es) | 2009-06-25 | 2012-02-13 | Astrazeneca Ab | Metodo para tratar un paciente que corre el riesgo de desarollar una ulcera asociada a antiinflamatorio no esteroide (aine). |
MY154683A (en) * | 2009-07-07 | 2015-07-15 | Boehringer Ingelheim Int | Pharmaceutical composition for a hepatitis c viral protease inhibitor |
ES2661812T3 (es) | 2009-10-16 | 2018-04-04 | Mochida Pharmaceutical Co., Ltd. | Composiciones |
BR112014016085A8 (pt) | 2011-12-28 | 2017-07-04 | Pozen Inc | composições aprimoradas e métodos para distribuição de omeprazol mais ácido acetilsalicílico |
CN102614115B (zh) * | 2012-04-26 | 2013-05-15 | 河南中医学院 | 一种双氯芬酸钠自乳化软膏 |
US9849115B2 (en) | 2013-08-27 | 2017-12-26 | Vasilios Voudouris | Bendamustine pharmaceutical compositions |
KR102343494B1 (ko) * | 2015-01-21 | 2021-12-24 | 모치다 세이야쿠 가부시키가이샤 | ω3 지방산의 자기 유화 조성물 |
EP3988091A1 (en) * | 2015-08-07 | 2022-04-27 | InFirst Healthcare Limited | Solid solution compositions for nsaids |
CN113440481B (zh) * | 2021-08-13 | 2022-06-14 | 湖南慧泽生物医药科技有限公司 | 伊布替尼的自微乳组合物 |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
JPS59227870A (ja) * | 1983-06-07 | 1984-12-21 | Yamanouchi Pharmaceut Co Ltd | 新規2−グアニジノチアゾリン誘導体ならびにその製造法 |
US4554276A (en) * | 1983-10-03 | 1985-11-19 | Pfizer Inc. | 2-Amino-5-hydroxy-4-methylpyrimidine derivatives |
US4552899A (en) * | 1984-04-09 | 1985-11-12 | Analgesic Associates | Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
US4766117A (en) * | 1984-10-11 | 1988-08-23 | Pfizer Inc. | Antiinflammatory compositions and methods |
US4704278A (en) * | 1984-10-17 | 1987-11-03 | American Home Products Corp (Del) | Fluidized magaldrate suspension |
US4676984A (en) * | 1985-08-14 | 1987-06-30 | American Home Products Corp. | Rehydratable antacid composition |
US4757060A (en) * | 1986-03-04 | 1988-07-12 | Bristol-Myers Company | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers |
US4965065A (en) * | 1986-04-29 | 1990-10-23 | Bristol-Myers Squibb Company | Gastroprotective process and compositions |
US5043358A (en) * | 1986-03-04 | 1991-08-27 | Bristol-Myers Squibb Company | Gastroprotective process |
US5037815A (en) * | 1986-03-04 | 1991-08-06 | Bristol-Myers Squibb Co. | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 - and H2 -receptor blockers |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US5260333A (en) * | 1986-08-08 | 1993-11-09 | Bristol Myers Squibb Company | Effect of a combination of a terbutaline, diphenhydramine and ranitidine composition on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
US5204118A (en) * | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
JPH06506198A (ja) * | 1991-03-04 | 1994-07-14 | ワーナー−ランバート・コンパニー | 種々な剤形の非ステロイド性抗炎症剤の新規な塩/イオン対 |
ES2130152T3 (es) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto. |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
IT1256345B (it) * | 1992-08-20 | 1995-12-01 | Esteri nitrici di derivati dell'acido 2-(2,6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione | |
IT1256450B (it) * | 1992-11-26 | 1995-12-05 | Soldato Piero Del | Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione |
US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
CH686761A5 (de) * | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
DK66493D0 (da) * | 1993-06-08 | 1993-06-08 | Ferring A S | Praeparater, isaer til brug ved behandling af inflammatoriske tarmsygdomme eller til at opnaa forbedret saarheling |
US6312704B1 (en) * | 1993-09-30 | 2001-11-06 | Gattefosse, S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
US6054136A (en) * | 1993-09-30 | 2000-04-25 | Gattefosse S.A. | Orally administrable composition capable of providing enhanced bioavailability when ingested |
FR2710535B1 (fr) * | 1993-09-30 | 1995-11-24 | Gattefosse Ets Sa | Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion. |
WO1995009831A1 (en) * | 1993-10-06 | 1995-04-13 | Nicox S.A. | Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
US5514663A (en) * | 1993-10-19 | 1996-05-07 | The Procter & Gamble Company | Senna dosage form |
WO1995011024A1 (en) * | 1993-10-19 | 1995-04-27 | The Procter & Gamble Company | Picosulphate dosage form |
US6025395A (en) * | 1994-04-15 | 2000-02-15 | Duke University | Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
US5643960A (en) * | 1994-04-15 | 1997-07-01 | Duke University | Method of delaying onset of alzheimer's disease symptoms |
CA2190087C (en) * | 1994-05-10 | 2005-08-02 | Piero Del Soldato | Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic activities |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5955451A (en) * | 1995-05-12 | 1999-09-21 | The University Of Texas System Board Of Regents | Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein |
EP0760237A1 (en) * | 1995-08-30 | 1997-03-05 | Cipla Limited | Oil-in-water microemulsions |
SE9600070D0 (sv) * | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US6231888B1 (en) * | 1996-01-18 | 2001-05-15 | Perio Products Ltd. | Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps |
SE510666C2 (sv) * | 1996-12-20 | 1999-06-14 | Astra Ab | Nya Kristallmodifikationer |
US6160020A (en) * | 1996-12-20 | 2000-12-12 | Mcneill-Ppc, Inc. | Alkali metal and alkaline-earth metal salts of acetaminophen |
SE510643C2 (sv) * | 1997-06-27 | 1999-06-14 | Astra Ab | Termodynamiskt stabil omeprazol natrium form B |
SK284616B6 (sk) * | 1997-07-29 | 2005-07-01 | Pharmacia & Upjohn Company | Farmaceutická kompozícia pre kyslé lipofilné zlúčeniny vo forme samoemulgujúcej formulácie |
US6395298B1 (en) * | 1997-10-31 | 2002-05-28 | Pharmacia Corporation | Gellan gum tablet coating |
WO1999038512A1 (en) * | 1998-01-30 | 1999-08-05 | Sepracor Inc. | S-lansoprazole compositions and methods |
JP2002501897A (ja) * | 1998-01-30 | 2002-01-22 | セプラコール, インク. | R−ランソプラゾール組成物及び方法 |
AU3843999A (en) * | 1998-05-07 | 1999-11-23 | Elan Corporation, Plc | Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems |
EP0984012A3 (en) * | 1998-08-31 | 2001-01-10 | Pfizer Products Inc. | Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
ID28275A (id) * | 1998-09-28 | 2001-05-10 | Warner Lambert Co | Penghantaran kolon dan enterik yang menggunakan kapsul-kapsul hpmc |
US6485747B1 (en) * | 1998-10-30 | 2002-11-26 | Monsanto Company | Coated active tablet(s) |
BR9916063A (pt) * | 1998-12-11 | 2002-01-22 | Pharmasolutions Inc | Composições auto-emulsificantes para medicamentos fracamente solúveis em água |
US6635281B2 (en) * | 1998-12-23 | 2003-10-21 | Alza Corporation | Gastric retaining oral liquid dosage form |
US6267985B1 (en) * | 1999-06-30 | 2001-07-31 | Lipocine Inc. | Clear oil-containing pharmaceutical compositions |
US6294192B1 (en) * | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
US6126816A (en) * | 1999-07-14 | 2000-10-03 | Ruiz, Jr.; Reuben F. | Wastewater treatment device |
US6787164B2 (en) * | 2000-02-23 | 2004-09-07 | Bioselect Innovations, Inc. | Composition and method for treating the effects of diseases and maladies |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
US20020044962A1 (en) * | 2000-06-06 | 2002-04-18 | Cherukuri S. Rao | Encapsulation products for controlled or extended release |
SE0002476D0 (sv) * | 2000-06-30 | 2000-06-30 | Astrazeneca Ab | New compounds |
US6544556B1 (en) * | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
US20020045184A1 (en) * | 2000-10-02 | 2002-04-18 | Chih-Ming Chen | Packaging system |
FR2818905A1 (fr) * | 2000-12-28 | 2002-07-05 | Cll Pharma | Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile |
-
2000
- 2000-03-08 SE SE0000773A patent/SE0000773D0/xx unknown
-
2001
- 2001-03-06 BR BR0109014-3A patent/BR0109014A/pt not_active Application Discontinuation
- 2001-03-06 IL IL15142701A patent/IL151427A0/xx active IP Right Grant
- 2001-03-06 AU AU2001237876A patent/AU2001237876B2/en not_active Ceased
- 2001-03-06 DK DK01910305T patent/DK1267832T3/da active
- 2001-03-06 KR KR1020027011731A patent/KR100771317B1/ko not_active IP Right Cessation
- 2001-03-06 MX MXPA02008657A patent/MXPA02008657A/es active IP Right Grant
- 2001-03-06 UA UA2002086883A patent/UA82979C2/ru unknown
- 2001-03-06 WO PCT/SE2001/000467 patent/WO2001066088A1/en active Application Filing
- 2001-03-06 PT PT01910305T patent/PT1267832E/pt unknown
- 2001-03-06 CA CA2401498A patent/CA2401498C/en not_active Expired - Fee Related
- 2001-03-06 CZ CZ20023005A patent/CZ20023005A3/cs unknown
- 2001-03-06 EE EEP200200500A patent/EE200200500A/xx unknown
- 2001-03-06 AU AU3787601A patent/AU3787601A/xx active Pending
- 2001-03-06 CN CN018061613A patent/CN1416335B/zh not_active Expired - Fee Related
- 2001-03-06 ES ES01910305T patent/ES2220728T3/es not_active Expired - Lifetime
- 2001-03-06 CN CN201010156308A patent/CN101862453A/zh active Pending
- 2001-03-06 RU RU2002122744/15A patent/RU2270675C9/ru not_active IP Right Cessation
- 2001-03-06 EP EP01910305A patent/EP1267832B1/en not_active Expired - Lifetime
- 2001-03-06 AT AT01910305T patent/ATE268162T1/de not_active IP Right Cessation
- 2001-03-06 SK SK1257-2002A patent/SK285982B6/sk not_active IP Right Cessation
- 2001-03-06 HU HU0300882A patent/HUP0300882A3/hu unknown
- 2001-03-06 NZ NZ521009A patent/NZ521009A/en unknown
- 2001-03-06 DE DE60103627T patent/DE60103627T2/de not_active Expired - Lifetime
- 2001-03-06 US US10/220,791 patent/US20030161846A1/en not_active Abandoned
- 2001-03-06 TR TR2004/01906T patent/TR200401906T4/tr unknown
- 2001-03-06 PL PL358595A patent/PL202683B1/pl not_active IP Right Cessation
- 2001-03-06 JP JP2001564741A patent/JP4663197B2/ja not_active Expired - Fee Related
- 2001-03-07 MY MYPI20011045A patent/MY127237A/en unknown
-
2002
- 2002-08-22 ZA ZA200206740A patent/ZA200206740B/en unknown
- 2002-09-03 IS IS6539A patent/IS6539A/is unknown
- 2002-09-06 NO NO20024272A patent/NO20024272L/no not_active Application Discontinuation
-
2003
- 2003-04-16 HK HK03102781A patent/HK1050632A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200401906T4 (tr) | Kendini emülsifiye ilaç sistemi, yağ ajanı seçime bağlıdır. | |
ATE387178T1 (de) | Gestreifte flüssige körperreinigungszusammensetzungen mit einer reinigungsphase und einer separaten vorteilhaften phase mit einer wasser-in-öl-emulsion | |
TNSN01123A1 (fr) | Formes posologiques nouvelles a liberation controlee | |
TW200613004A (en) | External preparation of solid/oil type | |
SE0000774D0 (sv) | New formulation | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
SE0102993D0 (sv) | New self emulsifying drug delivery system | |
TR200201966A2 (tr) | Farmasötik terkip. | |
BRPI0417585A (pt) | composição pregabalina | |
AR028752A1 (es) | Composicion adecuada para la preparacion de una emulsion de aceite en agua | |
BRPI0504082A (pt) | emulsões refrescantes medicinais | |
TH100976B (th) | ระบบนำส่งยาแบบอีมัลชิฟายตัวเองชนิดใหม่ | |
AR027555A1 (es) | Nuevo sistema de administracion de farmacos emulsionante | |
KR970005289A (ko) | 디프사쿠스 사포닌 C(Dipsacus saponin C)를 유효성분으로 함유하는 비마약성 중추성 진통제 | |
FR2915391B1 (fr) | Composition pharmaceutique et/ou cosmetique contenant un principe actif antioxydant et activateur de l'energie cellulaire. | |
TH102356B (th) | ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่ | |
RU2004117047A (ru) | Туалетная бумага | |
DE60123419D1 (de) | Flüssige arzneizubereitungen für die orale verabreichung von unangenehm, bitterschmeckenden arzneimitteln | |
TH48989A3 (th) | สารผสมของสารให้ความชุ่มชื้นแก่ผิวหนังซึ่งมีสารควบคุมไขผิวหนัง | |
TH102356A (th) | ระบบนำส่งยาแบบอีมัลซิฟายตัวเองชนิดใหม่ | |
TH51723B (th) | (เมทิลซัลโฟนิล) ฟีนิล-2-(5h)-ฟูราโนน ที่เป็นตัวขัดขวาง cox-2 |